The Science of Collagen Loss: Why Your Skin Changes After 40
Collagen does not simply "run out" as you age. Its decline is driven by specific biological processes — UV exposure, inflammation, hormonal change, and mechanical stress — that we can measure, predict, and partially reverse.
This content is for informational purposes only and does not constitute medical advice. Please consult your GP or healthcare provider.
"Collagen loss" is one of the most overused phrases in the beauty industry — deployed in product marketing, clinic promotions, and lifestyle articles with a confidence that rarely matches the nuance of the underlying science. As a physician, I find this frustrating, because the biology of collagen is genuinely fascinating, clinically relevant, and far more useful to patients when it is explained accurately.
What Collagen Actually Is
Collagen is the most abundant protein in the human body, accounting for roughly 75% of the dry weight of skin. It is not a single molecule but a family of at least 28 distinct types, each with a specific structural role. In the skin, Types I and III are predominant; Type I provides tensile strength (the resistance to stretching and tearing), while Type III contributes to the skin's elasticity and is particularly prominent in younger skin.
Collagen molecules are triple helices — three amino acid chains wound around each other in a structure that is extraordinarily strong per unit weight. These helices assemble into fibrils, which in turn organise into fibres and then into the dense collagen network of the dermis. This architecture is what gives young skin its taut, resilient character.
The Biology of Collagen Decline
Collagen decline with age is not simply a matter of production slowing down. It involves a complex interplay of reduced synthesis and accelerated degradation.
Fibroblast senescence. Fibroblasts — the cells that produce collagen — accumulate oxidative damage over time and gradually enter a state of senescence, in which they remain metabolically active but no longer divide or produce collagen effectively. Senescent fibroblasts also secrete pro-inflammatory cytokines (the "senescence-associated secretory phenotype"), which further damage the surrounding matrix.
Matrix metalloproteinase activity. Matrix metalloproteinases (MMPs) are enzymes that break down extracellular matrix components, including collagen. They are essential for tissue remodelling but become dysregulated with age and UV exposure. Chronic sun exposure dramatically upregulates MMP-1 (collagenase) and MMP-3 activity, accelerating collagen breakdown. This is the primary biological mechanism behind photoageing, which accounts for the majority of visible skin ageing in most people.
Reactive oxygen species. Free radicals — reactive oxygen species generated by UV radiation, pollution, smoking, and metabolic processes — damage collagen fibres directly and impair fibroblast function. Antioxidant defences, including superoxide dismutase, catalase, and glutathione, decline with age, leaving the skin less protected.
Glycation. Advanced glycation end-products (AGEs) form when glucose reacts non-enzymatically with collagen proteins. This cross-links collagen fibres, making them stiff and resistant to normal remodelling. Glycated collagen cannot be efficiently broken down and replaced, leading to accumulation of dysfunctional matrix.
Hormonal decline. As discussed in detail in our article on menopause and skin, oestrogen directly stimulates fibroblast collagen synthesis. Its decline at menopause produces an accelerated phase of collagen loss superimposed on the background age-related decline.
Quantifying the Loss
By age 40, most women have lost 10–20% of their peak dermal collagen content. By menopause, the cumulative loss is typically in the range of 25–30%. The subsequent decline of roughly 2% per year compounds over the following decades. These numbers are clinically meaningful: the difference between skin with 80% of its original collagen versus skin with 50% is visible, palpable, and functionally significant.
What Can Be Done?
The good news is that fibroblasts retain their capacity to be stimulated to produce collagen even in older skin. Several well-evidenced interventions exploit this:
Retinoids. Retinoic acid (tretinoin/Retin-A) and its precursors (retinol, retinaldehyde) are the most extensively studied topical anti-ageing compounds. They work via nuclear retinoid receptors to directly upregulate collagen gene expression and downregulate MMP activity. The evidence for their efficacy in increasing dermal collagen content is substantial and spans decades of research.
Vitamin C. Ascorbic acid is a co-factor for prolyl hydroxylase, the enzyme essential for stabilising the collagen triple helix. Without adequate vitamin C, collagen cannot form correctly. Topically applied vitamin C (in stable, high-concentration formulations) also provides antioxidant protection against UV-generated free radicals.
Polynucleotides (PDRN/PN). These injectable treatments — derived from purified salmon DNA fragments — stimulate fibroblast proliferation and activity via adenosine A2A receptor agonism. The clinical evidence for their efficacy in improving skin quality and collagen density has grown substantially in recent years.
Radiofrequency and focused ultrasound. Energy-based devices that heat the dermis stimulate the heat-shock response in fibroblasts, triggering new collagen synthesis. They can be effective for both prevention and treatment of established collagen loss.
Sunscreen. This bears repeating: the single most evidence-based, cost-effective intervention for preserving dermal collagen is daily broad-spectrum SPF50 sunscreen. UV radiation is the dominant driver of MMP upregulation and direct collagen degradation. No treatment programme makes sense without it as its foundation.
The Role of Physician Oversight
Understanding the mechanisms of collagen loss allows a physician to design a programme that targets multiple pathways simultaneously — stimulating synthesis, reducing degradation, protecting against ongoing damage, and replacing what has been lost with temporary scaffold where appropriate. This is the framework we use at London & Glow for every patient presenting with concerns about skin ageing in Edmonton.
The goal is never to chase youth. It is to optimise the biology you have, preserve what can be preserved, and restore what can reasonably be restored — always in a manner appropriate to your individual skin, your hormonal status, and your goals.
References
- Lephart ED. (2018). Skin aging and oxidative stress: Equol's anti-aging effects via biochemical and molecular mechanisms. Ageing Research Reviews, 31:36–54.
- Durai PC, et al. (2019). Aging in elderly: chronological versus photoageing. Indian Journal of Dermatology, 64(1):34–9.
- Mukherjee S, et al. (2019). Retinoids in the treatment of skin aging: updated evidence and clinical perspectives. Clinical Interventions in Aging, 14:1325–38.
- Rattanawiwatpong P, et al. (2020). Anti-aging and brightening effects of a topical treatment containing vitamin C, vitamin E, and raspberry leaf cell culture extract. Journal of Cosmetic Dermatology, 19(3):671–6.
- Aldag C, et al. (2016). Skin rejuvenation using cosmetic products containing growth factors, cytokines, and matrikines: a review of the literature. Clinical, Cosmetic and Investigational Dermatology, 9:411–9.
- NICE. (2023). Menopause: diagnosis and management. NICE guideline NG23. National Institute for Health and Care Excellence.